July 2009--Albert Ko, MD, of the Division of Infectious Diseases, received a 3-year, $2.8 million phase II Small Business Innovative Research Grant (SBIR) from the NIH to Fully Develop a Rapid Diagnostic Test for Leptospirosis
Albert Ko, M.D., of the Division of Infectious Diseases, received a 3-year, $2.8 million phase II Small Business Innovative Research Grant (SBIR) from the NIH to fully develop a rapid diagnostic test for leptospirosis. Dr. Ko received this grant in collaboration with Chembio Diagnostic Systems, Inc., a U.S. company serving the increasing global demand for rapid tests needed for the prevention and treatment of infectious diseases and other conditions.
Contact
Weill Cornell Medical College
Center for Global Health
440 E. 69th Street
New York, NY 10021
phone: 212-746-6680
fax: 212-746-9744
e-mail: globalhealthweb@med.cornell.edu
Web Manager/Editor: Lindsey Reif